Sustained Connexin43 Mimetic Peptide Release From Loaded Nanoparticles Reduces Retinal and Choroidal Photodamage
Author(s) -
Nasir Mat Nor,
Cindy X. Guo,
Ilva D. Rupenthal,
Ying-Shan Chen,
Colin Green,
Mónica L. Acosta
Publication year - 2018
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.17-22829
Subject(s) - retina , retinal , glial fibrillary acidic protein , inflammation , erg , electroretinography , ophthalmology , outer nuclear layer , chemistry , in vivo , medicine , pathology , immunohistochemistry , immunology , biology , neuroscience , microbiology and biotechnology
To evaluate the long-term effect on inflammation and inflammasome activation of intravitreally delivered connexin43 mimetic peptide (Cx43MP) in saline or incorporated within nanoparticles (NPs) for the treatment of the light-damaged rat eye.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom